WO2021252891A3 - In silico generated target lists - Google Patents

In silico generated target lists Download PDF

Info

Publication number
WO2021252891A3
WO2021252891A3 PCT/US2021/037004 US2021037004W WO2021252891A3 WO 2021252891 A3 WO2021252891 A3 WO 2021252891A3 US 2021037004 W US2021037004 W US 2021037004W WO 2021252891 A3 WO2021252891 A3 WO 2021252891A3
Authority
WO
WIPO (PCT)
Prior art keywords
dysfunctional
methods
cells
preferentially expressed
markers
Prior art date
Application number
PCT/US2021/037004
Other languages
French (fr)
Other versions
WO2021252891A2 (en
Inventor
Ronald Herbst
Yang Lee
Original Assignee
Pyxis Oncology, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pyxis Oncology, Inc. filed Critical Pyxis Oncology, Inc.
Publication of WO2021252891A2 publication Critical patent/WO2021252891A2/en
Publication of WO2021252891A3 publication Critical patent/WO2021252891A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Physiology (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to methods for identifying gene targets by interrogating genes preferentially expressed with dysfunctional T cell markers, systems for generating an in silico target list preferentially expressed with dysfunctional T cell markers and with or without regulatory T cells (Treg) markers, methods of treating cancer by interrogating genes preferentially expressed with dysfunctional T cell markers and with or without Treg markers, methods of treating cancer by interrogating genes preferentially expressed by T effector cells and not by dysfunctional T cells or regulatory T cells (Tregs), and methods of treating autoimmune disease.
PCT/US2021/037004 2020-06-11 2021-06-11 In silico generated target lists WO2021252891A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063037687P 2020-06-11 2020-06-11
US63/037,687 2020-06-11
US202063040600P 2020-06-18 2020-06-18
US63/040,600 2020-06-18

Publications (2)

Publication Number Publication Date
WO2021252891A2 WO2021252891A2 (en) 2021-12-16
WO2021252891A3 true WO2021252891A3 (en) 2022-01-20

Family

ID=76744990

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/037004 WO2021252891A2 (en) 2020-06-11 2021-06-11 In silico generated target lists

Country Status (1)

Country Link
WO (1) WO2021252891A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180100201A1 (en) * 2015-06-29 2018-04-12 The Broad Institute Inc. Tumor and microenvironment gene expression, compositions of matter and methods of use thereof
WO2018209324A2 (en) * 2017-05-11 2018-11-15 The Broad Institute, Inc. Methods and compositions of use of cd8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180100201A1 (en) * 2015-06-29 2018-04-12 The Broad Institute Inc. Tumor and microenvironment gene expression, compositions of matter and methods of use thereof
WO2018209324A2 (en) * 2017-05-11 2018-11-15 The Broad Institute, Inc. Methods and compositions of use of cd8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof

Also Published As

Publication number Publication date
WO2021252891A2 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
Geis et al. Silencing and transcriptional regulation of endogenous retroviruses: an overview
Tessé et al. Localization and roles of Ski8p protein in Sordaria meiosis and delineation of three mechanistically distinct steps of meiotic homolog juxtaposition
Lai et al. Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: Trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei
Levine et al. P53 and the defenses against genome instability caused by transposons and repetitive elements
Lubelsky et al. DNA replication and transcription programs respond to the same chromatin cues
WO2020219682A3 (en) Gene knock-outs to improve t cell function
JP2018082709A5 (en)
Izhar et al. Genomic assay reveals tolerance of DNA damage by both translesion DNA synthesis and homology-dependent repair in mammalian cells
WO2017027423A9 (en) Engineered crispr-cas9 compositions and methods of use
Alleva et al. Moving and stopping: Regulation of chromosome movement to promote meiotic chromosome pairing and synapsis
Zhao et al. Alternative lengthening of telomeres (ALT) in tumors and pluripotent stem cells
WO2019144126A8 (en) Cannabinoids and derivatives for promoting immunogenicity of tumor and infected cells
MX2019014516A (en) Method for knocking out target gene in t cell in vitro and crrna used in the method.
Lee et al. O-linked N-acetylglucosamine transferase (OGT) interacts with the histone chaperone HIRA complex and regulates nucleosome assembly and cellular senescence
WO2022120094A3 (en) Compositions and methods for the targeting of bcl11a
Tůmová et al. Structural organization of very small chromosomes: study on a single-celled evolutionary distant eukaryote Giardia intestinalis
Wiebe et al. The barrier to autointegration factor: interlocking antiviral defense with genome maintenance
Baller et al. Access to DNA establishes a secondary target site bias for the yeast retrotransposon Ty5
He et al. DNA methylation and regulatory elements during chicken germline stem cell differentiation
CN115052984A8 (en) Methods and systems for identifying target genes
Wang et al. CtIP-mediated DNA resection is dispensable for IgH class switch recombination by alternative end-joining
Krause et al. MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR
CN118064467A8 (en) Two or more target chimeric antigen receptor gene engineering vector and application thereof
Lavia et al. An epigenetic LINE-1-based mechanism in cancer
WO2021252891A3 (en) In silico generated target lists

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21737310

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21737310

Country of ref document: EP

Kind code of ref document: A2